StreetInsider.com News Articles

Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery

Thu, 05 Sep 2024 08:00:00 -0400

WALTHAM, Mass.--(BUSINESS WIRE)-- Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and X-Chem, leader in DNA-encoded library (DEL) technology, today announced a collaboration agreement focused on accelerating early-stage drug discovery.

X-Chem’s DEL technology streamlines hit finding by simultaneously screening up to billions of DNA-tagged compounds, identifying potential start points with high efficiency and precision.

In partnership with Evotec’s screening platforms and capabilities, X-Chem is providing access to its DEL technology, including DELflex, a traditional experimental DEL solution, and HITMiner, a machine learning solution, leveraging

Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery

Thu, 05 Sep 2024 08:00:00 -0400

X-Chem’s DEL technology streamlines hit finding by simultaneously screening up to billions of DNA-tagged compounds, identifying potential start points with high efficiency and precision.

Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery

Thu, 05 Sep 2024 08:00:00 -0400

X-Chem’s DEL technology streamlines hit finding by simultaneously screening up to billions of DNA-tagged compounds, identifying potential start points with high efficiency and precision.

Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery

Thu, 05 Sep 2024 08:00:00 -0400

X-Chem’s DEL technology streamlines hit finding by simultaneously screening up to billions of DNA-tagged compounds, identifying potential start points with high efficiency and precision.

Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery

Thu, 05 Sep 2024 08:00:00 -0400

X-Chem’s DEL technology streamlines hit finding by simultaneously screening up to billions of DNA-tagged compounds, identifying potential start points with high efficiency and precision.

Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery

Thu, 05 Sep 2024 08:00:00 -0400

X-Chem’s DEL technology streamlines hit finding by simultaneously screening up to billions of DNA-tagged compounds, identifying potential start points with high efficiency and precision.

Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery

Thu, 05 Sep 2024 08:00:00 -0400

X-Chem’s DEL technology streamlines hit finding by simultaneously screening up to billions of DNA-tagged compounds, identifying potential start points with high efficiency and precision.

Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery

Thu, 05 Sep 2024 08:00:00 -0400

X-Chem’s DEL technology streamlines hit finding by simultaneously screening up to billions of DNA-tagged compounds, identifying potential start points with high efficiency and precision.

Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery

Thu, 05 Sep 2024 08:00:00 -0400

X-Chem’s DEL technology streamlines hit finding by simultaneously screening up to billions of DNA-tagged compounds, identifying potential start points with high efficiency and precision.

Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery

Thu, 05 Sep 2024 08:00:00 -0400

X-Chem’s DEL technology streamlines hit finding by simultaneously screening up to billions of DNA-tagged compounds, identifying potential start points with high efficiency and precision.

Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery

Thu, 05 Sep 2024 08:00:00 -0400

X-Chem’s DEL technology streamlines hit finding by simultaneously screening up to billions of DNA-tagged compounds, identifying potential start points with high efficiency and precision.

Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery

Thu, 05 Sep 2024 08:00:00 -0400

X-Chem’s DEL technology streamlines hit finding by simultaneously screening up to billions of DNA-tagged compounds, identifying potential start points with high efficiency and precision.

Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery

Thu, 05 Sep 2024 08:00:00 -0400

X-Chem’s DEL technology streamlines hit finding by simultaneously screening up to billions of DNA-tagged compounds, identifying potential start points with high efficiency and precision.

Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery

Thu, 05 Sep 2024 08:00:00 -0400

X-Chem’s DEL technology streamlines hit finding by simultaneously screening up to billions of DNA-tagged compounds, identifying potential start points with high efficiency and precision.